Burney Company’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,379
Closed -$238K 585
2025
Q1
$238K Sell
18,379
-270
-1% -$3.57K 0.01% 536
2024
Q4
$238K Sell
18,649
-4,612
-20% -$55.8K 0.01% 552
2024
Q3
$259K Sell
23,261
-51,629
-69% -$569K 0.01% 543
2024
Q2
$841K Sell
74,890
-325,434
-81% -$3.79M 0.03% 341
2024
Q1
$4.97M Sell
400,324
-135,348
-25% -$1.77M 0.19% 129
2023
Q4
$7.49M Buy
535,672
+14,758
+3% +$205K 0.32% 82
2023
Q3
$7.69M Buy
520,914
+13,870
+3% +$195K 0.36% 71
2023
Q2
$6.55M Buy
507,044
+379,501
+298% +$4.32M 0.3% 90
2023
Q1
$1.25M Buy
+127,543
New +$1.36M 0.06% 280

Other funds holding DVAX

Burney Company's DVAX Position: Q2 2025 in Review

Burney Company sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 18,379 shares — an estimated $238K sold.

Burney Company first reported a position in DVAX in Q1 2023 and held it in 9 quarters. The position peaked at $7.69M in Q3 2023. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Burney Company reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Burney Company sold 18,379 Dynavax Technologies shares in Q2 2025, an estimated $238K.
  • Burney Company first reported a position in Dynavax Technologies in Q1 2023 and held it in 9 quarters.
  • Burney Company's Dynavax Technologies position peaked at $7.69M in Q3 2023.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Burney Company's 13F filing for Q2 2025, filed 5 Aug 2025.